Jørgensen P J, Hørder M, Blaabjerg O, Hyltoft Petersen P, Haas V, Olsson V
Scand J Clin Lab Invest Suppl. 1984;172:71-7.
In this subproject the analysis of S-calcium was used for evaluation of the specified system of internal quality control. Decisions on acceptance or rejection of series were based on a non-human pool with a calcium concentration near the upper reference limit. In the parallel system, specimens from patients and healthy individuals were used together with other non-human pools to disclose changes in accuracy. The results were examined for false rejections and false acceptances. In all the rejections based on a mean rule with 9 controls and a pfr of 0.01, the parallel system supported the decisions. On 18 occasions the series were rejected based on a range rule with a pfr of 0.05. Ten of the rejections were confirmed by the parallel system, and the remaining eight times of the 165 series were close to the expected five per cent of false rejections. The matrix effect estimated from the human and non-human serum pools was less than 15 per cent of the total variation. This supported the convenient use of non-human control materials in the analysis of S-calcium. The total variation, CVt, was estimated to be in the range of 0.027-0.030. The median of the patient results could be a valuable tool in quality control, whereas the mean of patient results within the reference limits is of no value. In conclusion, the investigation confirmed the validity of a system for internal control of a specified quality.
在这个子项目中,采用对S-钙的分析来评估特定的内部质量控制体系。系列样本的接受或拒收决策基于一个钙浓度接近参考上限的非人样本池。在平行系统中,患者和健康个体的样本与其他非人样本池一起使用,以揭示准确性的变化。对结果进行了假拒收和假接受的检查。在所有基于9个对照且假拒收率为0.01的均值规则的拒收中,平行系统支持这些决策。有18次系列样本基于假拒收率为0.05的极差规则被拒收。其中10次拒收得到平行系统的确认,在165个系列样本中,其余8次接近预期的5%的假拒收率。从人和非人血清样本池估计的基质效应小于总变异的15%。这支持了在S-钙分析中方便地使用非人对照材料。总变异系数CVt估计在0.027 - 0.030范围内。患者结果的中位数可能是质量控制中的一个有价值的工具,而参考范围内患者结果的均值则没有价值。总之,该调查证实了特定质量内部控制体系的有效性。